A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in men

Pierre Van Damme; Chris J. L. M. Meijer; Dorothee Kieninger; Anne Schuyleman; Stephane Thomas; Alain Luxembourg; Martine Baudin

doi:10.1016/j.vaccine.2016.06.056

A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in men

Pierre Van Damme, Chris J. L. M. Meijer, Dorothee Kieninger, Anne Schuyleman, Stephane Thomas, Alain Luxembourg, Martine Baudin

Pathology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	4205-4212
Journal	Vaccine
Volume	34
Issue number	35
DOIs	https://doi.org/10.1016/j.vaccine.2016.06.056
Publication status	Published - 29 Jul 2016

Access to Document

10.1016/j.vaccine.2016.06.056

Cite this

@article{401f84703cf141018eb99e74a1934317,

title = "A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in men",

keywords = "Human papilloma virus, Anogenital cancers, Anogenital warts, Immunogenicity, Safety, Nine-valent human papilloma virus vaccine",

author = "{Van Damme}, Pierre and Meijer, {Chris J. L. M.} and Dorothee Kieninger and Anne Schuyleman and Stephane Thomas and Alain Luxembourg and Martine Baudin",

year = "2016",

month = jul,

day = "29",

doi = "10.1016/j.vaccine.2016.06.056",

language = "English",

volume = "34",

pages = "4205--4212",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "35",

}

TY - JOUR

T1 - A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in men

AU - Van Damme, Pierre

AU - Meijer, Chris J. L. M.

AU - Kieninger, Dorothee

AU - Schuyleman, Anne

AU - Thomas, Stephane

AU - Luxembourg, Alain

AU - Baudin, Martine

PY - 2016/7/29

Y1 - 2016/7/29

KW - Human papilloma virus

KW - Anogenital cancers

KW - Anogenital warts

KW - Immunogenicity

KW - Safety

KW - Nine-valent human papilloma virus vaccine

U2 - 10.1016/j.vaccine.2016.06.056

DO - 10.1016/j.vaccine.2016.06.056

M3 - Article

C2 - 27354258

SN - 0264-410X

VL - 34

SP - 4205

EP - 4212

JO - Vaccine

JF - Vaccine

IS - 35

ER -